West Ham United v Leicester City: Premier League – live
North Korea behind $1.5bn hack of crypto exchange ByBit, says FBI
Trump threatens China with additional 10% tariff in escalation of trade war
Qantas posts $1.39bn profit as holidaymakers flock to Jetstar
Chinese fishing fleets using North Korean forced labour in potential breach of sanctions, report claims
Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
More Stories
Microsoft unveils chip it says could bring quantum computing within years
Ex-US security officials urge funding for science research to keep up with China
Virologist Wendy Barclay: ‘Wild avian viruses are mixing up their genetics all the time. It’s like viral sex on steroids’